Bypassing immune rejection in stem cell-based therapies
In an article featured in the latest issue of STEM CELLS, a research group from Stanford University describes a novel regimen for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research Archive
Family history of diabetes increases the risk of prediabetes by 26 per cent
A study involving more than 8,000 participants has shown that people with a family history of diabetes see their risk of…
Clinical trials in India in a crisis: Does it matter?
Dr Prem Pais, Head, Division of Clinical Research and Training, St John’s Research Institute, Bangalore, makes a powerful case for…
Cheaper anti-cancer drug effective in treating most common cause of blindness in older adults
Two drug treatments Lucentis and Avastin are equally effective in treating neovascular or wet age-related macular degeneration
’Our products are safe for juvenile diabetics as well as pregnant, lactating and nursing…
Recently, DSK Nutrition Research Centre has launched two new products for diabetes which do not contain any artificial sweeteners.…
Shorter and cheaper drug trials in pipeline with new research
Chicago Booth professor suggests adaptive model that could save lives with quicker results
Hepatitis B virus control, identifying proteins in mutation management
Researchers at Kanazawa University Graduate School of Medical Science used an avian counterpart for HBV duck HBV (DHBV) to…
Genetic testing of breast cancer: The widening horizon
A bird’s eye view of breast cancer prevalence, diagnosis and the role of BRCA1 and BRCA2 gene testing, from Dr Faisal Khan, Sr…
Playing by protocol
Designing and maintaining a protocol is one of the most challenging aspects of any clinical trial. Sachin Jagdale analyses
Novartis receives positive opinion from CHMP for Lucentis
Lucentis recommended for approval in EU to treat patients with visual impairment due to choroidal neovascularization secondary to…
Stem cell study could aid quest to combat range of diseases
To better understand and develop treatments for diseases such as multiple sclerosis, Parkinson’s disease and muscular degeneration…
Personal genomics and its role in creating lifelong wellness
Pankaj Mankad, Director – Physician, Xcode Life Sciences, Chennai, looks into the role and current limitations of personal…
Novartis drug significantly extends time without disease progression in women with HER2 positive…
Efficacy and safety data from the BOLERO-3 trial were assessed as part of a prospectively planned analysis
India develops $1 rotavirus vaccine
The vaccine reduces the incidence of diarrhoea by more than half during the first year of the child's life and protects against…
From Trash to Treasure
Manipal Institute of Regenerative Medicine (MIRM) has initiated a course in regenerative medicine. Looking at the prospect that…
In situ gelling polymeric drug delivery system
Dr Pradnya Palekar Shanbhag, Associate Professor in Pharmaceutics, Department of Pharmaceutics and Prajal P. Pandhare, Vivekanand…
Regulatory impact on clinical trial insurance
Deepali A Rao, Head, Specialty Lines, India Insure Risk Management & Insurance Broking Services, talks about the benefits of…
Developing a herbal-based drug for Hepatitis B
Dr Pralhad Patki, Head, Medical Services & Clinical Trials, The Himalaya Drug Company, narrates how the company applied their…
Key link between obesity and type 2 diabetes discovered
Cases of diabetes have more than doubled since 1980
Drug-eluting stent use in peripheral artery disease shows promising results
Drug-eluting stents could offer a less invasive option